Genscript Biotech Corporation (HKG: 1548)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.18
-0.42 (-3.96%)
Nov 22, 2024, 4:08 PM HKT

Genscript Biotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
1,010839.53625.7490.1390.85273.35
Upgrade
Revenue Growth (YoY)
42.71%34.17%27.67%25.39%42.98%18.33%
Upgrade
Cost of Revenue
468.1429.98321.62207.58134.9593.06
Upgrade
Gross Profit
541.49409.55304.08282.52255.89180.29
Upgrade
Selling, General & Admin
417.33387.74350.81302.48197.68125.61
Upgrade
Research & Development
461.88432.83390.1358.4263.4186.02
Upgrade
Operating Expenses
885.49825.34742.06661.81460.44311.64
Upgrade
Operating Income
-343.99-415.79-437.98-379.29-204.55-131.35
Upgrade
Interest Expense
-29.27-27.51-13.27-2.38-1.42-0.78
Upgrade
Interest & Investment Income
91.0573.1913.226.558.018.35
Upgrade
Earnings From Equity Investments
-----0.6-0.31
Upgrade
Currency Exchange Gain (Loss)
62.11----3.62
Upgrade
Other Non Operating Income (Expenses)
-11.49-15.09-0.96-3.52-85.777.58
Upgrade
EBT Excluding Unusual Items
-231.6-385.2-438.98-378.63-284.33-112.88
Upgrade
Impairment of Goodwill
-1.17-1.17-11.48---
Upgrade
Gain (Loss) on Sale of Investments
-31.1745.8818.77-138.732.43-0.81
Upgrade
Asset Writedown
-47.97-10.49----
Upgrade
Pretax Income
-311.91-350.98-431.69-517.36-281.9-113.69
Upgrade
Income Tax Expense
13.084.14-3.720.96-0.483.83
Upgrade
Earnings From Continuing Operations
-325-355.12-427.97-518.33-281.42-117.52
Upgrade
Minority Interest in Earnings
147.98259.64201.12159.6276.4820.6
Upgrade
Net Income
-177.01-95.48-226.85-358.71-204.95-96.91
Upgrade
Net Income to Common
-177.01-95.48-226.85-358.71-204.95-96.91
Upgrade
Shares Outstanding (Basic)
2,1142,1092,0972,0311,9011,854
Upgrade
Shares Outstanding (Diluted)
2,1142,1092,0972,0311,9011,854
Upgrade
Shares Change (YoY)
0.43%0.58%3.28%6.83%2.53%0.78%
Upgrade
EPS (Basic)
-0.08-0.05-0.11-0.18-0.11-0.05
Upgrade
EPS (Diluted)
-0.08-0.05-0.11-0.18-0.11-0.05
Upgrade
Free Cash Flow
-273.15-539.36-336.41-269.83-272.97-140.33
Upgrade
Free Cash Flow Per Share
-0.13-0.26-0.16-0.13-0.14-0.08
Upgrade
Gross Margin
53.63%48.78%48.60%57.65%65.47%65.95%
Upgrade
Operating Margin
-34.07%-49.53%-70.00%-77.39%-52.33%-48.05%
Upgrade
Profit Margin
-17.53%-11.37%-36.26%-73.19%-52.44%-35.45%
Upgrade
Free Cash Flow Margin
-27.06%-64.25%-53.76%-55.06%-69.84%-51.33%
Upgrade
EBITDA
-282.22-358.52-388.9-341.57-174.71-112.36
Upgrade
EBITDA Margin
-27.95%-42.70%-62.15%-69.69%-44.70%-41.10%
Upgrade
D&A For EBITDA
61.7857.2749.0837.7229.8418.98
Upgrade
EBIT
-343.99-415.79-437.98-379.29-204.55-131.35
Upgrade
EBIT Margin
-34.07%-49.53%-70.00%-77.39%-52.33%-48.05%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.